Anjarium Biosciences logo

Anjarium Biosciences

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

3

Funding Rounds

$121.0m

Money raised

Overview

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

Funding series

Funding Series Analysis

The company Anjarium Biosciences has raised a total of $121m in funding over 3 rounds.

Key Insights:

  • Anjarium Biosciences Series A round, September 2021: $61m
  • Anjarium Biosciences September 2021 Series A Funding Round: $60m
Anjarium Biosciences logo
Anjarium Biosciences Series A round, September 2021 $61m
Anjarium Biosciences logo
Anjarium Biosciences September 2021 Series A Funding Round $60m

Industries

Anjarium Biosciences is active in the following industries: